viernes, 10 de agosto de 2018

Drug Safety and Availability > FDA updates on valsartan recalls

Drug Safety and Availability > FDA updates on valsartan recalls

U.S. Food and Drug Administration Header



An update to a previous MedWatch Safety Alert recall: Valsartan-Containing Product by: Hetero Labs Limited, labeled as Camber Pharmaceuticals - Update to Recall  was just added to the FDA Recalls webpage. 
 
You can read the complete recall alert at: https://www.fda.gov/Drugs/DrugSafety/ucm613916.htm

No hay comentarios: